Metabolic dysfunction associated fatty liver disease improves detection of high liver stiffness: The rotterdam study

Further Publications

Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States

J Hepatol

Kim D, Konyn P, Sandhu KK, Dennis BB, Cheung AC, Ahmed A

doi: 10.1016/j.jhep.2021.07.035

Hepatology

Metabolic associated fatty liver disease increases COVID-19 disease severity in non-diabetic patients

J Gastroenterol Hepatol.

Gao F, Zheng KI, Wang XB, Yan HD, Sun QF, Pan KH, Wang TY, Chen YP, George J, Zheng MH

doi: 10.1111/jgh.15112.

Hepatology

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Implications for liver transplantation

Liver Transpl

Younossi ZM

doi: 10.1002/lt.25003.

Hepatology

Nonalcoholic Fatty Liver Disease Increases Risk of Incident Chronic Kidney Disease: a Systematic Review and Meta-Analysis

Metabolism.

Mantovani A, Zaza G, Byrne CD, Lonardo A, Zoppini G, Bonora E, Targher G

doi: 10.1016/j.metabol.

Hepatology

A new definition for metabolic associated fatty liver disease: an international expert consensus statement

J Hepatol.

Eslam M, Newsome PN, Anstee QM, Targher G, Gomez MR, Zelber-Sagi S, Wong VW, Dufour JF, Schattenberg J, Arrese M, Valenti L, Shiha G, Tiribelli C, Yki-Järvinen H, Fan JG, Gronbaek H, Yilmaz Y, Cortez-Pinto H, Oliveira CP, Bedossa P, Adams LA, Zheng MH, Fouad Y, Chan WK, Mendez-Sanchez N, Ahn SH, Castera L, Bugianesi E, Ratziu V, George J

doi: 10.1016/j.jhep.2020.03.039.

Hepatology

Nonalcoholic Fatty Liver Disease and Fibrosis Associated With Increased Risk of Cardiovascular Events in a Prospective Study

Clin Gastroenterol Hepatol.

Baratta F, Pastori D, Angelico F, Balla A, Paganini AM, Cocomello N, Ferro D, Violi F, Sanyal AJ, Del Ben M

doi: 10.1016/j.cgh.2019.12.026.

Hepatology

Higher Sodium Intake Assessed by 24 Hour Urinary Sodium Excretion Is Associated with Non-Alcoholic Fatty Liver Disease: The PREVEND Cohort Study

J Clin Med.

van den Berg EH, Gruppen EG, Blokzijl H, Bakker SJL, Dullaart RPF

doi: 10.3390/jcm8122157.

Hepatology

Nonalcoholic Fatty Liver Disease and the Incidence of Myocardial Infarction: A Cohort Study

J Gastroenterol Hepatol.

Sinn DH, Kang D, Chang Y, Ryu S, Cho SJ, Paik SW, Song YB, Pastor-Barriuso R, Guallar E, Cho J, Gwak GY

doi: 10.1111/jgh.14856.

Hepatology

Association between non-alcoholic fatty liver disease and impaired cardiac sympathetic/parasympathetic balance in subjects with and without type 2 diabetes-The Cooperative Health Research in South Tyrol (CHRIS)-NAFLD sub-study

Nutr Metab Cardiovasc Dis

Targher G, Mantovani A, Grander C, Foco L, Motta B, Byrne CD, Pramstaller PP, Tilg H

doi: 10.1016/j.numecd.2021.08.037

Related content

Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States

Metabolic associated fatty liver disease increases COVID-19 disease severity in non-diabetic patients

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Implications for liver transplantation

Nonalcoholic Fatty Liver Disease Increases Risk of Incident Chronic Kidney Disease: a Systematic Review and Meta-Analysis

A new definition for metabolic associated fatty liver disease: an international expert consensus statement

Nonalcoholic Fatty Liver Disease and Fibrosis Associated With Increased Risk of Cardiovascular Events in a Prospective Study

Higher Sodium Intake Assessed by 24 Hour Urinary Sodium Excretion Is Associated with Non-Alcoholic Fatty Liver Disease: The PREVEND Cohort Study

Nonalcoholic Fatty Liver Disease and the Incidence of Myocardial Infarction: A Cohort Study

Association between non-alcoholic fatty liver disease and impaired cardiac sympathetic/parasympathetic balance in subjects with and without type 2 diabetes-The Cooperative Health Research in South Tyrol (CHRIS)-NAFLD sub-study